Through its Japanese subsidiary, BioGaia has signed two new exclusive distributor agreements for Japan with Nippon Kabaya Ohayo Holdings Inc.
One for sales of finished probiotic supplements with Lactobacillus reuteri and one for use of Lactobacillus reuteri as ingredient in food. Launches are planned to 2017.
The first agreement concerns the exclusive rights to sell probiotic supplements with BioGaia’s patented strains of Lactobacillus reuteri at drugstores, supermarkets and similar outlets. Depending on the product category, products will be sold under Kabaya, Ohayo and/or BioGaia brands and the main target segment is adults.
The other agreement is an exclusive license, giving Ohayo Dairy Products the rights to use strains of Lactobacillus reuteri in food, such as drinks and dairy products.
The agreements are long-term and include exclusivity fees and minimum royalties during the term of the contracts, which will have a substantial effect on BioGaia’s Japanese business. Owing to confidentiality, the amounts of the fees and the royalties cannot be disclosed.
Nippon Kabaya Ohayo Holdings Inc. is a privately owned company with headquarters in Tokyo and consisting of a group of 13 companies with more than 3000 employees.
Kabaya Foods and Ohayo Dairy, Japan's seventh largest confectionary and dairy companies, respectively, are both well-known brands with a strong presence in the confectionary and dairy markets.
“Through these two milestone agreements with Nippon Kabaya Ohayo Holdings Inc., we have secured another trusted partner in the complex Japanese market. In addition to the marketing and sales of our supplements we look forward to the creation of innovative functional foods based on our Lactobacillus reuteri strains,” says Axel Sjöblad, Managing Director, BioGaia.